Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.
Chew
D P
DP
Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Bhatt
D L
DL
Robbins
M A
MA
Mukherjee
D
D
Roffi
M
M
Schneider
J P
JP
Topol
E J
EJ
Ellis
S G
SG
D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000378:metabolism*; D000077144:Clopidogrel; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000097:blood / Q000401:mortality / Q000628:therapy*; D009820:Ohio; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D011292:Premedication; D012042:Registries; D015607:Stents; D016019:Survival Analysis; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D002097:C-Reactive Protein; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin